Yes, a large upgrade and when we find out FY18 EBITDA this will likely be an even larger earnings beat. Underscores how quickly things are improving and as so often occurs in the early stages of an up-cycle, management remains overly conservative and continues to beat expectations (inverse is true when cycle is tipping over). You want to be positioned early in the stock as the risk profile of disappointing in BOL is very low. Could there be a more hated company? Wonderful contrarian position particularly when perceptions of company quality are in large part driven by the cycle and these perceptions are likely to adjust and drive a re-rating post one or two more strong results. Also worth noting how non-promotional the company is. They beat Revenue guidance materially but did not even call it out.......
BOL Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)